文献速递性腺与生殖内分泌肥胖与代谢综合征

多囊卵巢综合征女性高血压发病率及预测因素:澳大利亚队列研究

Incidence and Predictors of Hypertension in a Cohort of Australian Women With and Without Polycystic Ovary Syndrome.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该研究基于澳大利亚女性健康纵向研究,对9508名21-42岁女性随访15年,比较有无多囊卵巢综合征(PCOS)者的高血压发病率。PCOS女性高血压发病率为17/1000人年,显著高于无PCOS者的10/1000人年(P=0.001)。校正BMI等因素后,PCOS与高血压风险增加37%独立相关(HR 1.37,95%CI 1.14-1.65),肥胖进一步加剧风险。

要点

  • PCOS女性高血压发病率为17/1000人年,显著高于无PCOS者的10/1000人年。
  • 校正BMI等因素后,PCOS与高血压风险增加37%独立相关(HR 1.37,95%CI 1.14-1.65)。
  • 肥胖PCOS女性高血压归因发病率差为15.8/1000人年,高于瘦PCOS女性的4.3/1000人年。

核心结论

  • PCOS女性从成年早期起高血压风险更高,且独立于BMI,肥胖进一步加剧风险。
  • 将PCOS纳入高血压风险分层评估可能有助于早期识别高血压。

研究设计与样本

  • 澳大利亚女性健康纵向研究的二次分析,随访2000年至2015年。
  • 共纳入9508名21-42岁女性,随机选自国家健康保险数据库。
  • 采用Cox比例风险模型进行生存分析,并用人时分析计算高血压发病率。

主要发现

  • PCOS女性高血压发病率为17/1000人年,无PCOS女性为10/1000人年(P=0.001)。
  • 8223名女性中681名(8.3%)自报医生诊断的PCOS。
  • 肥胖PCOS女性高血压归因发病率差为15.8/1000人年,年龄匹配的瘦PCOS女性为4.3/1000人年。
  • 校正BMI、高血压家族史、职业和2型糖尿病合并症后,PCOS与高血压风险增加37%独立相关(HR 1.37,95%CI 1.14-1.65)。

临床怎么用

  • 对PCOS女性应关注高血压风险,从成年早期开始定期监测血压。
  • 在高血压风险分层评估中可考虑纳入PCOS状态,以助早期识别。

局限性

  • PCOS状态基于自报医生诊断,可能存在错分偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: There are limited studies in large population-based settings examining the relationship between polycystic ovary syndrome (PCOS) and hypertension. OBJECTIVE: To evaluate incidence of hypertension among women with and without PCOS over a 15-year period. DESIGN: Secondary analysis of longitudinal data from the Australian Longitudinal Study on Women's Health. SETTING: General community. PARTICIPANTS: Women were randomly selected from the national health insurance database. 9508 women, aged 21-42 years, were followed up from 2000 to 2015. METHODS: We conducted survival analysis using Cox proportional hazards model to identify predictors of hypertension and person-time analysis to calculate incidence rates of hypertension. RESULTS: 9508 women were followed for 145 159 person years (PY), and 1556 (16.37%) women developed hypertension during follow-up. The incidence of hypertension was significantly higher (P = 0.001) among women with PCOS (17/1000 PY) compared to women without (10/1000 PY). Women with known PCOS status totaled 8223, of which 681 women (8.3%) had self-reported physician-diagnosed PCOS. Incidence rate difference of hypertension (cases attributable to PCOS) was 4-fold higher (15.8/1000 PY vs 4.3/1000 PY) among obese women with PCOS compared to age-matched lean women with PCOS. PCOS was independently associated with 37% greater risk of hypertension (hazard ratio 1.37, 95% confidence interval 1.14-1.65), adjusting for body mass index (BMI), family history of hypertension, occupation, and comorbidity with type 2 diabetes. CONCLUSIONS: Women with PCOS are more likely to develop hypertension from early adulthood, independent of BMI, which is further exacerbated by obesity. Including PCOS in hypertension risk stratification assessments may aid efforts in early identification of the disorder.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Joham AE, Kakoly NS, Teede HJ, et al. Incidence and Predictors of Hypertension in a Cohort of Australian Women With and Without Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2021. PMID: 33693653. doi:10.1210/clinem/dgab134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。